$3.43T
Total marketcap
$89.67B
Total volume
BTC 62.20%     ETH 8.76%
Dominance

Pfizer PFE Stock

24.24 USD {{ price }} 0.206694% {{change_pct}}%
Exchange
NYSE
Market Cap
137.81B USD
LOW - HIGH [24H]
24.12 - 24.38 USD
VOLUME [24H]
33.41M USD
{{ volume }}
P/E Ratio
17.56
Earnings per share
1.38 USD

Pfizer Price Chart

Pfizer PFE Financial and Trading Overview

Pfizer stock price 24.24 USD
Previous Close 24.19 USD
Open 24.21 USD
Bid 24.21 USD x 12600
Ask 24.26 USD x 5700
Day's Range 24.12 - 24.38 USD
52 Week Range 20.92 - 31.54 USD
Volume 33.41M USD
Avg. Volume 47.37M USD
Market Cap 137.81B USD
Beta (5Y Monthly) 0.491
PE Ratio (TTM) 17.565218
EPS (TTM) 1.38 USD
Forward Dividend & Yield 1.72 (7.11%)
Ex-Dividend Date July 25, 2025
1y Target Est 29.24 USD

PFE Valuation Measures

Enterprise Value 182.91B USD
Trailing P/E 17.565218
Forward P/E 8.273037
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 2.2062845
Price/Book (mrq) 1.5253917
Enterprise Value/Revenue 2.928
Enterprise Value/EBITDA 7.843

Trading Information

Pfizer Stock Price History

Beta (5Y Monthly) 0.491
52-Week Change -14.28%
S&P500 52-Week Change 12.74%
52 Week High 31.54 USD
52 Week Low 20.92 USD
50-Day Moving Average 23.4 USD
200-Day Moving Average 25.85 USD

PFE Share Statistics

Avg. Volume (3 month) 47.37M USD
Avg. Daily Volume (10-Days) 38.54M USD
Shares Outstanding 5.69B
Float 5.68B
Short Ratio 2.67
% Held by Insiders 0.056%
% Held by Institutions 67.59%
Shares Short 106.73M
Short % of Float 1.88%
Short % of Shares Outstanding 1.88%

Dividends & Splits

Trailing Annual Dividend Rate 1.69
Trailing Annual Dividend Yield 6.98%
5 Year Average Dividend Yield 454.00%
Payout Ratio 1.2246
Last Split Factor 1054:1000

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2024
Most Recent Quarter (mrq) March 30, 2025
Next Fiscal Year End December 31, 2025

Profitability

Profit Margin 12.62%
Operating Margin (ttm) 35.16%
Gross Margin 74.42%
EBITDA Margin 37.33%

Management Effectiveness

Return on Assets (ttm) 4.79%
Return on Equity (ttm) 8.61%

Income Statement

Revenue (ttm) 62.46B USD
Revenue Per Share (ttm) 11.02 USD
Quarterly Revenue Growth (yoy) -7.79%
Gross Profit (ttm) 46.49B USD
EBITDA 23.32B USD
Net Income Avi to Common (ttm) 7.87B USD
Diluted EPS (ttm) 1.38
Quarterly Earnings Growth (yoy) -4.79%

Balance Sheet

Total Cash (mrq) 17.32B USD
Total Cash Per Share (mrq) 3.05 USD
Total Debt (mrq) 62.4B USD
Total Debt/Equity (mrq) 68.84 USD
Current Ratio (mrq) 1.258
Book Value Per Share (mrq) 15.891

Cash Flow Statement

Operating Cash Flow (ttm) 13.99B USD
Levered Free Cash Flow (ttm) 15.05B USD

Profile of Pfizer

Country United States
State NY
City New York
Address 66 Hudson Boulevard East
ZIP 10001-2192
Phone 212 733 2323
Website https://www.pfizer.com
Industry Drug Manufacturers - General
Sector(s) Healthcare
Full Time Employees 81000

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Octagam, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Q&A For Pfizer Stock

What is a current PFE stock price?

Pfizer PFE stock price today per share is 24.24 USD.

How to purchase Pfizer stock?

You can buy PFE shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Pfizer?

The stock symbol or ticker of Pfizer is PFE.

Which industry does the Pfizer company belong to?

The Pfizer industry is Drug Manufacturers - General.

How many shares does Pfizer have in circulation?

The max supply of Pfizer shares is 5.69B.

What is Pfizer Price to Earnings Ratio (PE Ratio)?

Pfizer PE Ratio is 17.56521800 now.

What was Pfizer earnings per share over the trailing 12 months (TTM)?

Pfizer EPS is 1.38 USD over the trailing 12 months.

Which sector does the Pfizer company belong to?

The Pfizer sector is Healthcare.

Pfizer PFE included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
S&P 500 (Yahoo.com) GSPC 6204.95 USD
+0.52
3.34B USD 6174.97 USD 6215.08 USD 3.34B USD
S&P 500 INDEX SPX 6204.95 USD
+0.52
3.33B USD 6174.97 USD 6215.08 USD 3.33B USD
S&P 100 SP100 3045.8 USD
+0.47
1.61B USD 3030.26 USD 3051.92 USD 1.61B USD
Dow Jones Composite Average DJA 13730.3 USD
+0.35
810.62M USD 13665.9 USD 13742.61 USD 810.62M USD
The Capital Strength Index NQCAPST 3325.34 USD
+0.62
3305.33 USD 3329.79 USD
^DRG DRG 924.73 USD
+0.56
NASDAQ US Broad Dividend Achiev DAA 3914.52 USD
+0.79
3892.06 USD 3919.24 USD
Nasdaq US Smart Pharmaceuticals NQSSPH 1362.05 USD
+0.18
1356.07 USD 1365.99 USD
Nasdaq Factor Family US Low Vol NQFFUSLV 1725.92 USD
+0.66
1710.93 USD 1727.16 USD
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD 2100.38 AUD 1390.15 USD
<0.01
2100.38 AUD 1390.15 USD 2100.38 AUD 1390.15 USD
The Capital Strength Net Total NQCAPSTN 3927.11 USD
+0.64
3903.49 USD 3932.36 USD
Nasdaq US Low Volatility Divide LVDA 1264.77 USD
+0.72
1253.01 USD 1265.96 USD
Dorsey Wright Momentum Plus Div DWAMY 1516.26 USD
+0.67
1506.14 USD 1517.15 USD
Better Investing 100 BIXX 245.36 USD
0
NYSE Composite Index NYA 20429.55 USD
+0.45
Nasdaq US Price Setters Index NQPRCE 2974.47 USD
+0.84
2950.32 USD 2976.59 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 3140.12 USD
+0.81
3125.52 USD 3143.04 USD
Nasdaq CRD Global Sustainabilit NQCRD 1735.62 USD
0
1715.94 USD 1757.95 USD